Related Experiment Video
Updated: Dec 22, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.4K
Recent Progress on Lipid Intake and Chronic Kidney Disease
1College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
Biomed Research International
|May 9, 2020
Summary
Lipid abnormalities are a direct cause of chronic kidney disease (CKD), creating a detrimental cycle. Understanding lipid metabolism in CKD offers potential for new treatments.
Area of Science:
- Nephrology
- Metabolic Research
- Cardiovascular Science
Background:
- Chronic kidney disease (CKD) is frequently linked to significant alterations in circulating lipoproteins.
- Renal lipid metabolism plays a crucial role in the pathogenesis and progression of CKD.
Purpose of the Study:
- To elaborate on the mechanisms underlying CKD and associated lipid uptake abnormalities.
- To propose and support the viewpoint that lipid abnormalities are a direct cause of CKD, establishing a vicious cycle.
Main Methods:
- Theoretical elucidation of lipid metabolism in CKD.
- Experimental verification of the role of lipid intake and accumulation.
- Analysis of the influence of lipid dysregulation on CKD progression.
Main Results:
- Evidence supports the hypothesis that lipid abnormalities directly initiate and exacerbate CKD.
- Lipid intake and accumulation were identified as key factors influencing CKD development.
- The interplay between lipid metabolism and renal dysfunction forms a self-perpetuating cycle.
Conclusions:
- Lipid abnormalities are not merely associated with CKD but are a causative factor.
- Further investigation into lipid metabolism in CKD is essential for developing targeted therapeutic strategies.
- Modulating lipid metabolism presents a promising avenue for novel CKD treatments.
More Related Videos
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
266
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
266
01:25Chronic Kidney Disease I: Introduction
466
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
466
01:24Chronic Kidney Disease II: Clinical Manifestations
454
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
454
01:18Chronic Kidney Disease IV: Nursing Management
229
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
229
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
113
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
113
01:29Acute Kidney Injury III: Clinical Manifestations
652
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
652